Document:

EXHIBIT 4.5

Wi-LAN INC.

DEFERRED STOCK UNIT PLAN

FOR DIRECTORS AND DESIGNATED EMPLOYEES

 

ARTICLE 1 - PURPOSE STATEMENT 

 

		1.01	The purpose of this Plan is to provide selected officers, employees and consultants (“Designated
Employees”) of the Corporation and members of the Board (“Directors”) with compensation opportunities
which:

 

		(a)	are compatible with shareholder interests;

 

		(b)	will encourage a sense of ownership; and

 

		(c)	will enhance the Corporation’s ability to retain key personnel and reward significant performance
achievements.

 

ARTICLE 2 - DEFINITIONS

 

For purposes of this Plan, the following terms
are defined as set forth below:

 

		2.01	“Account” means the account maintained for record-keeping purposes by the Corporation
in the name of each Participant composed of all Units issued to the Participant after the Effective Date including Units that have
not been redeemed or terminated in accordance with the terms of the Plan.

 

		2.02	“Agreement” has the meaning set out in Section 5.01 hereof.

 

		2.03	“Applicable Withholding Taxes” has the meaning set out in Section 11.01 hereof.

 

		2.04	“Award Date” means, unless otherwise determined by the Committee:

 

		(1)	in respect of a Director, not later than 10 Business Days following the end of each fiscal quarter;

 

		(2)	in respect of a Designated Employee, not later than 10 Business Days following approval of an annual
bonus payment to a Designated Employee.

 

		2.05	“Board” means the board of directors of the Corporation.

 

		2.06	“Business Day” means any day, other than a Saturday or a Sunday, on which the
Toronto Stock Exchange is open for trading.

 

		2.07	“Cash Equivalent” means the amount of money expressed in Canadian dollars equal
to the number of Units multiplied by, at the Committee’s discretion, either (i) the average closing trading price of the
Shares on the Toronto Stock Exchange on the 10 Business Days immediately preceding the Redemption Date of the Units; or (ii) the
closing trading price per Share on the Toronto Stock Exchange on the last trading day preceding the Redemption Date of the Units.

 

		2.08	“Committee” means the Compensation Committee of the Board or such other committee
or persons designated by the Board, including the Board itself, for the purpose of administering the Plan.

 

		2.09	“Corporation” means Wi-LAN Inc. and any reference in this Plan to an action
by the Committee means an action by or under the authority of Corporation.

 

		2.10	“Deferred Amount” has the meaning set out in Section 6.01 hereof.

 

		2.11	“Designated Employees” has the meaning set out in Section 1.01 hereof.

 

		2.12	“Directors” has the meaning set out in Section 1.01 hereof.

 

		2.13	“Director’s Fees” means the retainer payable to a Director for service
as a member of the Board as well as board chair fee, committee chair fees, board committee member fees and board meeting fees.

 

		2.14	“Dividend Rate” has the meaning set out in Section 6.03 hereof.

 

    	-1-

    	 

    
 

		2.15	“Effective Date” has the meaning set out in Section 14.01 hereof.

 

		2.16	“Participant” means a Director or Designated Employee who elects to receive
Units under the Plan in accordance with Section 4.03.

 

		2.17	“Plan” means the Wi-LAN Inc. Deferred Stock Unit Plan for Directors and Designated
Employees as set forth herein, and amended from time to time.

 

		2.18	“Redemption Date” means the date upon which any Units are actually redeemed
in accordance with the provisions of this Plan.

 

		2.19	“Regulations” means the Income Tax Regulations (Canada).

 

		2.20	“Retirement”, in the case of Designated Employees, means retirement, including
early retirement, from (and for greater certainty ceasing to be employed by) the Corporation and, in the case of Directors, means
ceasing to be a Director (whether as a result of the resignation, not standing for re-election to the board or not being elected
or re-elected as a member of the board by the shareholders at a meeting, or for any other reason other than as a result of death).

 

		2.21	“Shares” means common shares in the capital of the Corporation.

 

		2.22	“Termination” means, in the case of a Designated Employee, the occurrence of
any act or event whether pursuant to an employment agreement or otherwise, including without limitation dismissal for cause, dismissal
without cause or resignation, which actually or effectively causes or results in the person’s ceasing, for whatever reason,
to be an employee of the Corporation, but for purposes of the Plan shall not include Retirement.

 

		2.23	“Unit” means a deferred stock unit that is issued under the Plan, and which
upon the meeting of all of the conditions specified herein, is redeemable for either

 

		(a)	its Cash Equivalent; or

 

		(b)	Shares;

 

in accordance with the
provisions of this Plan.

 

		2.24	“Unitholder” means a Participant who has been issued Units under the Plan.

 

ARTICLE 3 - ADMINISTRATION

 

		3.01	The Plan will be unfunded and shall be administered by the Committee unless the Board determines
otherwise. The Committee may make, and may from time to time amend, such rules and provisions for the implementation and administration
of the Plan as it shall deem appropriate. Notwithstanding the foregoing, any amendment or suspension of the Plan shall be such
that the Plan continuously meets the requirements of paragraph 6801(d) of the Regulations or any successor provisions thereto.

 

		3.02	The interpretation and construction by the Committee of any provisions of the Plan and any rules
and resolutions concerning the Plan, unless otherwise determined by the Board, shall be final and conclusive and shall be applicable
with respect to and binding upon all Participants.

 

		3.03	The Committee shall establish such terms, conditions and limitations with respect to the issuance
of Units as may be necessary or desirable in order to ensure that the Plan achieves its objectives in compliance with all applicable
laws. In particular, without limiting the foregoing, the Committee may establish such terms, conditions and limitations in relation
to the issuance of Units (i) to any Designated Employee or Director who is not a resident of Canada or (ii) otherwise to any Designated
Employee or Director, as it determines to be necessary or advisable having regard to any securities, tax or other laws and regulations
or currency considerations which may be applicable to the Corporation or to such Designated Employee or Director in connection
with the issuance of Units.

 

		3.04	The Committee may appoint the Chief Executive Officer and/or any other Designated Employee or any
other qualified third party service provider to act on its behalf and in accordance with the determinations of the Committee to
administer the Plan and implement the decisions of the Committee and the Board, and the Committee may delegate its authority under
the Plan for such purpose.

 

    	-2-

    	 

    
 

		3.05	The Corporation shall pay all costs of administering the Plan.

 

		3.06	The maximum number of Shares reserved for issuance under the Plan is 430,000 Shares provided that
any Redemptions of Units for Shares will make new awards of Units available under the Plan effectively resulting in a re-loading
of the number of Shares reserved for issuance under the Plan, provided that the combined number of Shares reserved for issuance
under the Plan does not exceed 430,000 Shares at any given time. In addition:

 

		(a)	the maximum number of Shares reserved for issuance pursuant to Units granted to Insiders (as such
term is defined in the Securities Act (Ontario)) at any time may not exceed 10% of the Corporation’s issued and outstanding
Shares at any given time;

 

		(b)	the maximum number of Shares which may be issued to Insiders, within a one-year period, may not
exceed 10% of the Corporation’s issued and outstanding Shares at any given time;

 

		(c)	the maximum number of Shares which may be issued to any one Insider and the Associates (as such
term is defined in the Securities Act (Ontario)) of such Insider, within a one-year period, may not exceed 5% of the number
of the Corporation’s issued and outstanding Shares at any given time;

 

		(d)	the maximum number of Shares issuable to Insiders, at any time, under all security based compensation
arrangements (as such term is defined in the Toronto Stock Exchange Company Manual), cannot exceed 10% of the Corporation’s
issued and outstanding Shares at any given time;

 

		(e)	the number of Shares issued to Insiders, within any one year period, under all security based compensation
arrangements (as such term is defined in the Toronto Stock Exchange Company Manual), cannot exceed 10% of the Corporation’s
issued and outstanding Shares at any given time; and

 

		(f)	the number of Shares reserved for issuance to non-executive Directors shall not exceed 1.4% of the total number of issued and
outstanding Shares at any time.

 

ARTICLE 4 - ELIGIBILITY

 

		4.01	Subject to the provisions of the Plan and any relevant resolutions of the Board, the Committee
shall, in its sole discretion, determine or designate a method to determine, which Designated Employees and Directors, if any,
shall be eligible in any particular fiscal year to participate in the Plan and the terms and conditions of Unit awards. The judgment
of the Committee in the designation of Designated Employees eligible to participate in the Plan shall be final and conclusive.

 

		4.02	Subject to a determination by the Committee not to allow the issuance of Units in any particular
fiscal year, all Directors shall be eligible to participate in the Plan.

 

		4.03	Subject to Sections 4.01 and 4.02, Directors and Designated Employees may, on an annual basis,
elect to participate in the Plan and receive in Units, as applicable, Director’s Fees earned, or a portion thereof, or annual
bonus payments payable, or a portion thereof, in respect of a fiscal year by giving written notice to the Committee:

 

		(a)	in the case of a Director who is not newly appointed, within the last 90 day period of the fiscal
year preceding the fiscal year in which such amounts are earned, specifying an amount (expressed as a percentage) of such individual’s
Director’s Fees to be earned in the fiscal year following the fiscal year in which the election is made;

 

		(b)	in the case of a newly appointed Director, within 30 days of the individual’s appointment
as a Director, specifying an amount (expressed as a percentage), of the Director’s Fees to be earned in the fiscal year of
election after the date on which such election is made; and

 

		(c)	in the case of a Designated Employee, within the last 90 day period of the fiscal year preceding
the fiscal year in which such amounts are payable, specifying an amount (expressed as a percentage) of such individual’s
annual bonus payments payable in the fiscal year following the fiscal year in which the election is made.

 

Notwithstanding the foregoing,
for the fiscal year ending October 31, 2005, Directors and Designated Employees shall give the stipulated notice within 30 days
of the Effective Date.

 

    	-3-

    	 

    
 

		4.04	The Committee may, from time to time, determine what proportion of Director’s Fees or annual
bonuses are payable to Designated Employees, subject to the elections made by a Participant under Section 4.03.

 

ARTICLE 5 - ISSUANCE OF UNITS

 

		5.01	The issuance of Units shall be evidenced by a written agreement between the Corporation and the
Participant (the “Agreement”). The Agreement shall be confirmed in writing by the Corporation to the Participant
within the period of 10 Business Days following the Award Date.

 

ARTICLE 6 - ACCOUNTS

 

		6.01	The Committee shall direct management of the Corporation to establish an Account for each Participant.
All Units shall be credited to an Account as of the Award Date. The amount determined pursuant to the election referred to in Section
4.03 (the “Deferred Amount”) shall be expressed in Canadian dollars, and in each case, the number of Units (including
fractional Units) to be credited to an Account shall be determined by the Committee by dividing the Deferred Amount by either (i)
the average closing trading price of the Shares on the Toronto Stock Exchange on the 10 Business Days immediately preceding the
end of the relevant fiscal quarter in the case of Directors and on the 10 Business Days immediately preceding the Award Date in
the case of Designated Employees; or (ii) the closing trading price per Share on the Toronto Stock Exchange on the last trading
day preceding the end of the relevant fiscal quarter in the case of Directors and on the trading day immediately preceding the
Award Date in the case of Designated Employees, on which there was a closing price.

 

		6.02	The Accounts shall vest immediately but remain non-redeemable until such time one of the events
described in Articles 8 and 9 occurs.

 

		6.03	On the last day of each fiscal quarter of the Corporation or as soon as possible thereafter, the
Corporation shall determine whether any dividend has been paid on Shares during such fiscal quarter and, if so, the rate thereof
per Share (expressed as a percentage based on the closing Share price on the Toronto Stock Exchange on the record date) (the “Dividend
Rate”). Within 10 Business Days of the applicable fiscal quarter end, the Corporation shall credit each Account with
an additional number of Units equal to the number of Units in the respective Accounts on the record date for such dividend multiplied
by the Dividend Rate.

 

ARTICLE 7 - NON-ASSIGNABILITY / NON-TRANSFERABILITY

 

		7.01	Subject to Section 7.02, each Unit is non-assignable and non-transferable and, except in the case
of the Unitholder’s death or the appointment of a duly authorized legal representative for a Unitholder who becomes incapable,
shall be redeemable only by the Unitholder.

 

		7.02	The Units and any rights thereunder shall not be transferable otherwise than by the laws of succession
on the death of the Unitholder, and shall not be subject to attachment, execution or other similar process except to the extent
permitted by applicable law.

 

		7.03	Subject to Section 7.02, upon the death of the Unitholder, rights in respect of the Units that
are transferred to the Unitholder’s duly authorized legal representative or designated beneficiary shall only be exercised
by said duly authorized legal representative or designated beneficiary without further powers of transference or possible future
encumbrance.

 

ARTICLE 8 - REDEMPTION EVENTS

 

		8.01	Units shall not be redeemable except upon the occurrence of any one of the following events:

 

		(a)	the death of the Unitholder;

 

		(b)	the Retirement of the Unitholder; or

 

		(c)	the Termination of the Unitholder;

 

((a), (b) and (c) each,
a “Redemption Event”).

 

    	-4-

    	 

    
 

ARTICLE 9 - REDEMPTION

 

		9.01	Upon the occurrence of a Redemption Event, all Units in the Unitholder’s Account shall be
redeemable for their Cash Equivalent or Shares in accordance with this Section.

 

		9.02	Units that have become redeemable may be redeemed by written notice signed by the Unitholder or
its duly authorized legal representative in a form reasonably required by the Committee (the “Notice”), and
delivered to the Corporation:

 

		(i)	in the case of death or Retirement of a Unitholder, not later than 10 Business Days prior to the
end of the one year period following the date of death or Retirement, or December 10 of the calendar year following the year in
which the date of death or Retirement occurs; or

 

		(ii)	in the case of Termination, to the Corporation not later than 10 Business Days prior to the end
of the 90 day period following the date of the Termination;

 

((i) and (ii) each, a “Redemption
Period”).

 

		9.03	In the Notice, the Unitholder or the Unitholder’s duly authorized legal representative, as
the case may be, may elect to redeem the Units for their Cash Equivalent (determined in accordance with Section 9.07(a)) or Shares
(determined in accordance with Section 9.07(b)), or a combination thereof, however, such election will be subject to the approval
of the Committee. In all cases, the Committee shall have the final authority to determine whether the Units will be redeemed for
their Cash Equivalent, Shares or a combination thereof.

 

		9.04	At the end of a Redemption Period, all unredeemed Units in the Unitholder’s Account will
be redeemed for their Cash Equivalent, Shares or a combination thereof, at the sole discretion of the Committee.

 

		9.05	The redemption shall be effective at the end of a Redemption Period or 10 Business Days after receipt
of the Notice.

 

		9.06	The Corporation shall redeem the Units by delivery of:

 

		(i)	in the case of redemption for their Cash Equivalent, a cheque to the Unitholder or the Unitholder’s
duly authorized legal representative or designated beneficiary, as the case may be; and

 

		(ii)	in the case of redemption for Shares, a share certificate to the Unitholder or the Unitholder’s
duly authorized legal representative or designated beneficiary, as the case may be.

 

		9.07	Determination of Amounts.

 

		(a)	Cash Equivalent of Units. For purposes of determining the Cash Equivalent of Units, such
calculation will be made: (i) on the last day of the Redemption Period or (ii) on the date of the Notice, as the case may be, based
on, at the sole discretion of the Committee, either (A) the average closing trading price of the Shares on the Toronto Stock Exchange
on the 10 Business Days immediately preceding the Redemption Date or (B) the closing trading price per Share on the Toronto Stock
Exchange on the last trading day preceding the Redemption Date on which there was a closing price.

 

		(b)	Shares. At its option, the Corporation may elect to issue Shares from treasury or acquire
Shares on the open market.

 

		(i)	Issuance of Shares from Treasury. If the Corporation issues Shares from treasury, the number
of whole Shares to be issued will be equal to the number of Units in the applicable Unitholder’s Account less any deduction
or other withholding to satisfy any Applicable Withholding Taxes, such Shares will be issued in consideration for the past services
of the Unitholder to the Corporation and the entitlement of the Unitholder under this Plan shall be satisfied in full by such issuance
of Shares. The Corporation will also make a cash payment, less any Applicable Withholding Taxes, to the Unitholder with respect
to the value of fractional Units standing to the Unitholder’s credit after the maximum number of whole Shares has been issued
by the Corporation as described above.

 

    	-5-

    	 

    
 

		(ii)	Acquisition of Shares on Open Market. If the Corporation acquires Shares on the open market,
the number of whole Shares to be so acquired will be equal to the number of Units in the applicable Unitholder’s Account
less any deduction or other withholding to satisfy any Applicable Withholding Taxes and such Shares will be acquired through an
independent broker designated by the Committee (the “Designated Broker”). On the Redemption Date, or if the
Redemption Date is not a trading date for Shares on the Toronto Stock Exchange, on the next such trading date, the Corporation
shall advise the Designated Broker of the specified number of whole Shares to be purchased on behalf of the Unitholder. The Designated
Broker will purchase the specified number of Shares as soon as practicable after being notified by the Corporation. On or before
the date of settlement with respect to the purchase of the Shares by the Designated Broker, the Corporation, acting as agent for
the Unitholder, will pay the purchase price of the specified number of Shares to the Designated Broker, together with any reasonable
brokerage fees or commissions related thereto. The Corporation will also make a cash payment, less any Applicable Withholding Taxes,
to the Unitholder with respect to the value of fractional Units still standing to the Unitholder’s credit after the maximum
number of whole Shares has been purchased as described above.

 

		9.08	For the avoidance of doubt, in no event may the redemption of a Unitholder’s Units be made
later than the last day of the calendar year immediately following the calendar year in which the Redemption Event occurs.

 

ARTICLE 10 - ADJUSTMENTS

 

		10.01	Subject to any relevant resolutions of the Board, reasonable and appropriate adjustments may be
made by the Committee to preserve the intended benefits of the Plan for Participants with respect to Units issued or to be issued
in order to adjust for the effect of subdivision or consolidation of the Shares, payment of dividends in stock (other than dividends
in the ordinary course), reclassification or conversion of the Shares, recapitalization, reorganization, change of control or any
other event which, in the judgment of the Committee, necessitates action by way of adjustment to the terms of Units issued or to
be issued.

 

		10.02	Subject to any relevant resolutions of the Board, the judgment of the Committee with respect to
any such adjustments shall be conclusive and binding upon each Unitholder.

 

		10.03	No amount will be paid to, or in respect of, a Participant under the Plan to compensate for a downward
fluctuation in the price of the Shares nor will any other form of benefit be conferred upon, or in respect of, a Participant for
such purpose.

 

ARTICLE 11 - TAX MATTERS

 

		11.01	The Corporation may withhold from any payment made under the Plan the amount that the Corporation
deems necessary to satisfy its obligation, if any, to withhold federal, provincial, state or local income or other taxes or source
deductions (collectively, “Applicable Withholding Taxes”) arising in respect of the issuance of Units, their
redemption or any payment under the Plan.

 

ARTICLE 12 - AMENDMENT AND TERMINATION
OF PLAN

 

		12.01	The Board shall have the right, in its sole discretion, to
suspend or terminate this Plan or any portion thereof at any time, in accordance with applicable legislation, without obtaining
the approval of shareholders, provided, however, that (i) no suspension or termination of the Plan shall impair any of the
rights or obligations under any Unit previously granted without the consent of the Unitholder thereof; (ii) notification of any
such termination or suspension is sent to Unitholders of outstanding Units previously issued; and (iii) in the event of Plan termination,
redemption of any outstanding Units for their Cash Equivalent or Shares at the time of such termination shall be made in accordance
with Articles 8 and 9.

		12.02	The Board shall have the right, in its sole discretion, to
amend this Plan or any portion thereof at any time, in accordance with applicable legislation, without obtaining
the approval of shareholders; provided that: any amendment to any provision of the Plan will be subject
to any required regulatory approval and the provisions of applicable law, if any, that require the approval of shareholders.
Notwithstanding the foregoing, the Corporation will be required to obtain the approval
of the shareholders of the Corporation for any of the following amendments:

		(i)	amendments to the Plan which would increase the number of Shares issuable under the Plan, otherwise
than in accordance with Article 10 of the Plan;

 

    	-6-

    	 

    

 

 

		(ii)	amendments to Section 3.06 of the Plan which would increase the number of Shares issuable to Insiders
or issued to Insiders within any one year period, under the Plan, otherwise than in accordance with Article 10 of the Plan;

	   	(iii)	amendments to the formula used to calculate the number of Units credited to an Account as of the
Award Date set out in Section 6.1 with the intention of increasing the number of Units issuable to a Participant;

		(iv)	amendments that would permit the transfer
or assignation of Units for any reason other than in connection with a Unitholder’s estate planning; and

		(v)	amendments to the formula used to calculate the number of Shares from treasury to be delivered
to a Unitholder upon redemption for Shares set out in Section 9.07(b)(i) with the intention of increasing the entitlement of a
Unitholder thereunder.

		12.03	The Board shall not alter or impair any rights or increase any obligations with respect to a Unit
previously issued under the Plan without the consent of the holder thereof.

		12.04	Further, no amendment shall be made to the Plan if such amendment would cause the acceleration
of redemption of any outstanding Units for their Cash Equivalent or Shares at a time earlier than that provided for in Article
9.

ARTICLE 13 - RIGHTS NOT CONFERRED

 

		13.01	No Unitholder shall have any rights as a shareholder in respect of any Unit issued to it under
the Plan.

 

		13.02	The Plan and any Units granted hereunder shall not be construed to confer any right to employment.
The right of the Corporation to terminate at will (whether by dismissal, discharge or otherwise) any Unitholder’s employment
at any time is specifically reserved.

 

ARTICLE 14 - APPROVALS/EFFECTIVE DATE

 

		14.01	The Plan (or any amendment thereto) shall become effective on the date (the “Effective
Date”) when it (or any amendment thereto) has been adopted by the Board.

 

ARTICLE 15 - GENERAL

 

		15.01	No election may be made pursuant to Section 4.03, no issuance of Units will be made pursuant to
Section 5.01 and no notice of redemption may be given by a Unitholder pursuant to Article 9 when such Unitholder is in possession
of material, undisclosed and confidential information which would limit or restrict such person’s right to trade in securities
of the Corporation pursuant to the Securities Act (Ontario) as amended in any other similar provision of applicable law.
Subject to Section 9.06, the Committee may extend or change applicable election or Award Dates or time periods in its discretion
to ensure compliance as it may reasonably determine.

 

		15.02	The Plan and each Agreement shall be construed in accordance with the laws applicable in the Province
of Ontario and the parties shall agree that they shall attorn to the jurisdiction of the courts of the Province of Ontario with
respect to any and all actions brought in relation thereto.

 

		15.03	The Corporation and the Participants confirm their desire that this document along with all other
documents including all notices relating hereto, be written in the English language. La Compagnie et les membres confirment leur
volonté que ce document de même que tous les documents, y compris tout avis, s’y rattachant soient rédigés
en anglais.

 

    	-7-EMPLOYMENT AGREEMENT

 

This Employment
Agreement (this “Agreement”), dated February 6, 2012, by and between Adeona Pharmaceuticals, Inc., a corporation organized
under the laws of the State of Nevada (the “Corporation”), and C. Evan Ballantyne, an individual (the “Executive”).

 

1.           EMPLOYMENT;
DUTIES

 

(a)The Corporation hereby engages
and employs Executive as the Chief Financial Officer of the Corporation, and Executive hereby accepts such engagement and employment
as the Chief Financial Officer of the Corporation, for the term of this Agreement as long as Executive desires to serve. It is
expected that Executive shall have such duties, authorities and responsibilities commensurate with the duties, authorities and
responsibilities of persons in similar capacities in similarly sized companies and such other duties and responsibilities as the
Corporation’s Board of Directors shall designate that are consistent with the Executive’s position. Executive further
agrees to serve without additional compensation as an officer or director of any subsidiaries of the Corporation upon request of
the Board of Directors.

 

(b)Executive
shall devote substantially all of his professional time under this Agreement to the business of the Corporation. Executive’s
employment under this Agreement shall be Executive’s exclusive employment during the term of this Agreement.  Executive
may not engage, directly or indirectly, in any other business, investment, or activity that interferes with Executive's performance
of Executive's duties hereunder, is contrary to the interest of the Corporation or any of its subsidiaries, or requires any significant
portion of Executive's business time.  The foregoing notwithstanding, the parties recognize and agree that Executive
may engage in personal investments, other business activities and civic, charitable or religious activities which do not conflict
with the business and affairs of the Corporation or interfere with Executive's performance of his duties hereunder.  Executive
may not serve on the board of directors of any entity other than the Corporation during the Term (as hereinafter defined) without
the written approval of the Board of Directors.  Executive shall be permitted to retain any compensation received for
approved service on any unaffiliated corporation's board of directors.

(c)The Corporation shall pay or reimburse reasonable
travel, lodging, meal and related incidental costs of the Executive when the Executive is requested to travel to or from the Corporation’s
locations and while on business for the Corporation, consistent with the Corporation’s travel policies in effect from time
to time.

(d)The Corporation shall provide
a computer, cellular phone and office for Executive.

    	1

    	 

    

2.           TERM

 

The term (the “Term”) of
Executive’s employment shall be three (3) years from the execution date of this Agreement unless terminated earlier under
Section 9 of this Agreement. The parties may extend the Term for an additional three (3) year period upon mutual consent of Executive
and the Board of Directors of the Corporation, upon terms to be agreed upon by the parties.

 

3.           COMPENSATION

 

(a)As compensation for the performance
of his duties on behalf of the Corporation, Executive shall receive the following:

 

(i)           
Base Salary. Executive shall receive an annual base salary of Two Hundred Ninety-Eight Thousand Dollars ($298,000) for the
Term (the “Base Salary”), payable semi-monthly.

 

(ii)           
Bonus. The Executive shall be eligible for an annual bonus of up to fifty percent (50%) of his base salary payable in cash
or equity. Any bonus that may be awarded will be in the sole and absolute discretion of both the Compensation Committee and the
Board of Directors of the Corporation. The amount of such bonus shall depend on the achievement by the Executive and/or the Corporation
of certain objectives to be established by the Board or the Compensation Committee in consultation with the Executive, along with
such other factors the Board and Compensation Committee deems relevant. Any bonus for a given fiscal year shall be payable in one
lump sum upon approval by the Board of Directors of the Corporation or the Compensation Committee, which shall be obtained by the
Corporation on or about January 31 of the following year.

   

(b)The Corporation shall reimburse Executive for
all normal, usual and necessary expenses incurred by Executive, including all travel, lodging and entertainment, against receipt
by the Corporation, as the case may be, of appropriate vouchers or other proof of Executive’s expenditures and otherwise
in accordance with such Expense Reimbursement Policy as may from time to time be adopted by the Corporation.

 

(c)The Executive shall receive
a non-restricted option to purchase 425,000 shares of the Corporation’s publicly traded common stock. The option shall be
exercisable at the market price per share on the date hereof. The option will vest monthly on each monthly anniversary of the date
hereof and for thirty six (36) successive months while Executive is employed by the Corporation and such options will remain exercisable
for a period of ten (10) years from the date of grant, unless terminated earlier. Other terms of the option, including the period
to exercise such options following termination of employment, shall be according to the Corporation’s existing stock option
plan.

 

(d)The Corporation shall provide
Executive with full advance indemnification to the extent permitted by Nevada law, including indemnification for activities at
all subsidiaries.

 

(e)Executive shall be entitled
to four (4) weeks paid vacation and sick leave in accordance with the Corporation’s policies. The Corporation shall provide
Executive and his family with healthcare coverage pursuant to the Corporation’s healthcare insurance policy plan as well
as any other benefits provided to executive officers.

    	2

    	 

    

4.           REPRESENTATIONS
AND WARRANTIES BY EXECUTIVE

 

Executive hereby represents and warrants
to the Corporation as follows:

 

(a)           Neither
the execution and delivery of this Agreement nor the performance by Executive of his duties and other obligations hereunder violates
or will violate any statute, law, determination or award, or conflict with or constitute a default under (whether immediately,
upon the giving of notice or lapse of time or both) any prior employment agreement, contract, or other instrument to which Executive
is a party or by which he is bound.

 

(b)           Executive
has the full right, power and legal capacity to enter and deliver this Agreement and to perform his duties and other obligations
hereunder. This Agreement constitutes the legal, valid and binding obligation of Executive enforceable against him in accordance
with its terms. No approvals or consents of any persons or entities are required for Executive to execute and deliver this Agreement
or perform his duties and other obligations hereunder.

 

6.           CONFIDENTIAL
INFORMATION

 

(a)           Executive
agrees that during the course of his employment or at any time thereafter, he will not disclose or make accessible to any other
person, the Corporation’s products, services and technology, both current and under development, promotion and marketing
programs, lists, trade secrets and other confidential and proprietary business information of the Corporation or any affiliates
or any of their clients. Executive agrees: (i) not to use any such information for himself or others, and (ii) not to take any
such material or reproductions thereof from the Corporation’s facilities at any time during his employment by the Corporation
other than to perform his duties hereunder. Executive agrees immediately to return all such material and reproductions thereof
in his possession to the Corporation upon request and in any event upon termination of employment.

 

(b)           Except
with prior written authorization by the Corporation, Executive agrees not to disclose or publish any of the confidential, technical
or business information or material of the Corporation, its clients or any other party to whom the Corporation owes an obligation
of confidence, at any time during or after his employment with the Corporation.

 

(c)           In
the event that Executive breaches any provisions of this Section 6 or there is a threatened breach, then, in addition to any other
rights which the Corporation may have, the Corporation shall be entitled, without the posting of a bond or other security, to injunctive
relief to enforce the restrictions contained herein. In the event that an actual proceeding is brought in equity to enforce the
provisions of this Section 6, Executive shall not urge as a defense that there is an adequate remedy at law, nor shall the Corporation
be prevented from seeking any other remedies which may be available. In addition, Executive agrees that in the event that he breaches
the covenants in this Section 6, in addition to any other rights that the Corporation may have, Executive shall be required to
pay to the Corporation any amounts he receives in connection with such breach.

 

(d)           Executive
recognizes that in the course of his duties hereunder, he may receive from the Corporation or others information which may be considered
“material, non-public information” concerning a public company that is subject to the reporting requirements of the
United States Securities and Exchange Act of 1934, as amended. Executive agrees not to:

 

(i)           Buy
or sell any security, option, bond or warrant while in possession of relevant material, non-public information received from the
Corporation or others in connection herewith, and

    	3

    	 

    

 

(ii)           Provide
the Corporation with information with respect to any public company that may be considered material, non-public information, unless
first specifically agreed to in writing by the Corporation.

 

 7.           INVENTIONS DISCOVERED BY EXECUTIVE

 

Executive shall promptly disclose to
the Corporation any invention, improvement, discovery, process, formula, or method or other intellectual property, whether or not
patentable or copyrightable (collectively, "Inventions"), conceived or first reduced to practice by Executive, either
alone or jointly with others, while performing services hereunder (or, if based on any Confidential Information, within one (1)
year after the Term), (a) which pertain to any line of business activity of the Corporation, whether then conducted or then being
actively planned by the Corporation, with which Executive was or is involved, (b) which is developed using time, material or facilities
of the Corporation, whether or not during working hours or on the Corporation premises, or (c) which directly relates to any of
Executive’s work during the Term, whether or not during normal working hours. Executive hereby assigns to the Corporation
all of Executive’s right, title and interest in and to any such Inventions. During and after the Term, Executive shall execute
any documents necessary to perfect the assignment of such Inventions to the Corporation and to enable the Corporation to apply
for, obtain and enforce patents, trademarks and copyrights in any and all countries on such Inventions, including, without limitation,
the execution of any instruments and the giving of evidence and testimony, without further compensation beyond Executive’s
agreed compensation during the course of Executive’s employment. All such acts shall be done without cost or expense to Executive.
Executive shall be compensated for the giving of evidence or testimony after the term of Executive’s employment at the rate
of $1,000/day. Without limiting the foregoing, Executive further acknowledges that all original works of authorship by Executive,
whether created alone or jointly with others, related to Executive’s employment with the Corporation and which are protectable
by copyright, are "works made for hire" within the meaning of the United States Copyright Act, 17 U.S .C. (S) 101, as
amended, and the copyright of which shall be owned solely, completely and exclusively by the Corporation. If any Invention is considered
to be work not included in the categories of work covered by the United States Copyright Act, 17 U. S. C. (S) 101, as amended,
such work is hereby assigned or transferred completely and exclusively to the Corporation. Executive hereby irrevocably designates
counsel to the Corporation as Executive's agent and attorney-in-fact to do all lawful acts necessary to apply for and obtain patents
and copyrights and to enforce the Corporation's rights under this Section. This Section 7 shall survive the termination of this
Agreement. Any assignment of copyright hereunder includes all rights of paternity, integrity, disclosure and withdrawal and any
other rights that may be known as or referred to as "moral rights" (collectively "Moral Rights"). To the extent
such Moral Rights cannot be assigned under applicable law and to the extent the following is allowed by the laws in the various
countries where Moral Rights exist, Executive hereby waives such Moral Rights and consents to any action of the Corporation that
would violate such Moral Rights in the absence of such consent. Executive agrees to confirm any such waivers and consents from
time to time as requested by the Corporation.

 

8.NON-COMPETE; NON-SOLICITATION

 

(a)NON-COMPETE.  For
a period commencing on the date hereof and ending one (1) year after the date Executive ceases to be employed by the Corporation
(the "Non-Competition Period"), Executive shall not, directly or indirectly, either for himself or any other person,
own, manage, control, materially participate in, invest in, permit his name to be used by, act as consultant or advisor to, render
material services for (alone or in association with any person, firm, corporation or other business organization) or otherwise
assist in any manner any business which develops, markets or sells products in the field of gene therapy or that are directly competitive
with the products being developed or sold by the Corporation at the time of termination (collectively, a "Competitor").  Nothing
herein shall prohibit Executive from being a passive owner of not more than five percent (5%) of the equity securities of a Competitor
which is publicly traded, so long as he has no active participation in the business of such Competitor.

    	4

    	 

    

 

(b)NON-SOLICITATION.  During the Non-Competition
Period, Executive shall not, directly or indirectly, (i) induce or attempt to induce or aid others in inducing anyone working
at or for the Corporation to cease working at or for the Corporation, or in any way interfere with the relationship between the
Corporation and anyone working at or for the Corporation except in the proper exercise of Executive’s authority or (ii)
in any way interfere with the relationship between the Corporation and any customer, supplier, licensee or other business relation
of the Corporation.

 

(c)SCOPE.  If,
at the time of enforcement of this Section 8, a court shall hold that the duration, scope, area or other restrictions stated herein
are unreasonable under circumstances then existing, the parties agree that the maximum duration, scope, area or other restrictions
reasonable under such circumstances shall be substituted for the stated duration, scope, area or other restrictions.

 

(d)    INDEPENDENT
AGREEMENT.  The covenants made in this Section 8 shall be construed as an agreement independent of any other provisions
of this Agreement, and shall survive the termination of this Agreement.  Moreover, the existence of any claim or cause
of action of Executive against the Corporation or any of its affiliates, whether or not predicated upon the terms of this Agreement,
shall not constitute a defense to the enforcement of these covenants. 

(e)EXCEPTIONS. The Non-Competition
Period shall be reduced to a period ending on the six month anniversary of the date of termination of this Agreement if such termination
is by the Corporation without Just Cause (as defined in Section 9 below) or by the Executive for Good Reason (as defined in Section
9 below).

 

9.           TERMINATION

 

Executive’s employment hereunder
shall continue as set forth in Section 2 hereof unless terminated upon the first to occur of the following events:

 

(a)The Executive’s death.

 

(b)The Executive’s “Disability”,
meaning the Executive’s incapacity, due to physical or mental illness, which results in Executive having been absent from
fully performing his duties with the Company for a continuous period of more than sixty (60) days or more than ninety (90) days
in any period of three hundred sixty-five (365) consecutive days. In the event that
the Corporation intends to terminate the employment of Executive by reason of Disability, the Corporation shall give the Executive
no less than thirty (30) days’ prior written notice of the Corporation’s intention to terminate Executive’s employment.  The
Executive agrees, in the event of any dispute hereunder as to whether a Disability exists, and if requested by the Corporation,
to submit to a physical examination in the state of the Corporation’s executive offices by a licensed physician selected
by mutual agreement between the Corporation and the Executive, the cost of such examination to be paid by the Corporation. The
written medical opinion of such physician shall be conclusive and binding upon each of the parties hereto as to whether a Disability
exists and the date when such Disability arose. If the Executive refuses to submit to appropriate examinations by such physician
at the request of the Corporation, the determination of the Executive’s Disability by the Corporation in good faith will
be conclusive as to whether such Disability exists. This Agreement shall be interpreted and applied so as to comply with
the provisions of the Americans with Disabilities Act (to the extent that it is applicable) and any other applicable laws regarding
disability.

    	5

    	 

    

 

(c)          “Just
Cause”, meaning the Executive’s:

 

(i)gross insubordination;
acts of embezzlement or misappropriation of funds; fraud; dereliction of fiduciary obligations;

 

(ii)conviction
of a felony or other crime involving moral turpitude, dishonesty or theft;

 

(iii)willful
unauthorized disclosure of confidential information belonging to the Corporation or entrusted to the Corporation by a client;

 

(iv) material
violation of any provision of the Agreement, which is not cured by Executive within thirty (30) days of receiving written notice
of such violation by the Corporation;

 

(v) being under
the influence of drugs (other than prescription medicine or other medically-related drugs to the extent that they are taken in
accordance with their directions) during the performance of Executive’s duties under this Agreement;

 

(vi) engaging
in behavior that would constitute grounds for liability for harassment (as proscribed by the U.S. Equal Employment Opportunity
Commission Guidelines or any other applicable state or local regulatory body) or other egregious conduct that violates laws governing
the workplace;

 

(vii) willful failure to perform his written assigned tasks, where such failure is attributable to the fault
of Executive which is not cured by Executive within thirty (30) days of receiving written notice of such violation by the Corporation..

 

In the event that
the Corporation intends to terminate the employment of Executive by reason of Just Cause, the Corporation shall give the Executive
written notice of the Corporation’s intention to terminate Executive’s employment, and such termination may be effective
immediately, unless a cure period applies, in which case the termination date may not precede the expiration date of the applicable
cure period.

 

(d)         “Without
Just Cause”, meaning written notice by the Corporation to the Executive of a termination without Just Cause and other than
due to death or Disability.

  

(e)“Good Reason”,
meaning:

 

(i)a material
breach by the Corporation of the terms of this Agreement, which breach is not cured within thirty (30) days after notice thereof
from Executive; or

    	6

    	 

    

 

(ii)an assignment
to Executive of any duties materially inconsistent with Executive’s position(including status, office, title and reporting
requirements) authority, duties or responsibilities as contemplated by this Agreement which results in material diminution in
such position, authority, duties or responsibilities, specifically excluding for this purpose an isolated and insubstantial action
not taken in bad faith which is remedies by the Corporation after receipt of notice thereof given by Executive; or

 

(iii)  
a change in control which shall mean (a) any person becomes the beneficial owner (as term is defined in the Securities Exchange
Act of 1934) directly or indirectly, of securities representing more than fifty percent (50%) of the total voting power of Company’s
shares; or (b) a change in the composition of the Board of Directors as a result of which fewer than a majority of the directors
are Incumbent Directors.  Incumbent Directors shall mean directors who are either directors of the Company on the date
hereof or are elected by the Board of Directors with the affirmative vote of a majority of the Incumbent Directors at the time
of election; or (c) the Company merges with another corporation after which a majority of the shares of the resulting entity are
not held by shareholders of the Company prior to the merger.

 

In the event that
the Executive intends to terminate his employment for Good Reason, the Executive shall give the Corporation written notice of his
intention to terminate his employment, and such termination may be effective immediately, unless a cure period applies, in which
case the termination date may not precede the expiration date of the applicable cure period.

 

(f)           Without
Good Reason, meaning written notice by the Executive to the Corporation of a termination without Good Reason.

 

If the Executive’s
employment hereunder is terminated for any reason, the Executive or his estate as the case may be, will be entitled to receive
the accrued base salary, vacation pay, expense reimbursement and any other entitlements accrued by Executive under Section 2(b),
to the extent not previously paid (the sum of the amounts described in this subsection shall be hereinafter referred to as the
“Accrued Obligations”); provided, however, that if Executive’s employment is terminated (1) by
the Corporation without Just Cause or by the Executive for Good Reason then in addition to paying the Accrued Obligations the Corporation
shall continue to pay the Executive his then- current base salary and continue to provide benefits to the Executive at least equal
to those which he had at the time of termination for a period of six months after termination and (y) Executive shall have the
right to exercise any vested options until the earlier of the expiration of the severance or the expiration of the term of the
option, or (2) by reason of death or Disability, then in addition to paying the Accrued Obligations, Executive shall have the right
to exercise any vested options until the expiration of the term of the option. If Executive commences employment with another employer
and is eligible to receive medical or other welfare benefits under another employer-provider plan, the medical and other welfare
benefits to be provided by the Corporation as described herein shall terminate.

 

 

 

 

10.           NOTICES

 

Any notice or other communication under
this Agreement shall be in person or in writing and shall be deemed to have been given (i) when delivered personally against receipt
therefor, (ii) one (1) day after being sent by Federal Express or similar overnight delivery, (iii) three (3) days after being
mailed registered or certified mail, postage prepaid, return receipt requested, to either party at the address set forth above,
or to such other address as such party shall give by notice hereunder to the other party, or (iv) when sent by facsimile, followed
by oral confirmation and with a hard copy sent as in (ii) or (iii) above.

    	7

    	 

    

 

11.           SEVERABILITY
OF PROVISIONS

 

If any provision of this Agreement shall
be declared by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced in whole or in part, such
provision shall be interpreted so a to remain enforceable to the maximum extent permissible consistent with applicable law and
the remaining conditions and provisions or portions thereof shall nevertheless remain in full force and effect and enforceable
to the extent they are valid, legal and enforceable, and no provision shall be deemed dependent upon any other covenant or provision
unless so expressed herein.

 

12.           ENTIRE
AGREEMENT MODIFICATION

 

This Agreement contains the entire agreement
of the parties relating to the subject matter hereof, and the parties hereto have made no agreements, representations or warranties
relating to the subject matter of this Agreement which are not set forth herein. No modification of this Agreement shall be valid
unless made in writing and signed by the parties hereto.

 

  13.           BINDING
EFFECT

 

The rights, benefits, duties and obligations
under this Agreement shall inure to, and be binding upon, the Corporation, its successors and assigns, and upon Executive and his
legal representatives. This Agreement constitutes a personal service agreement, and the performance of Executive’s obligations
hereunder may not be transferred or assigned by Executive.

 

14.           NON-WAIVER

 

The failure of either party to insist
upon the strict performance of any of the terms, conditions and provisions of this Agreement shall not be construed as a waiver
or relinquishment of future compliance therewith, and said terms, conditions and provisions shall remain in full force and effect.
No waiver of any term or condition of this Agreement on the part of either party shall be effective for any purpose whatsoever
unless such waiver is in writing and signed by such party.

 

15           GOVERNING
LAW, DISPUTE RESOLUTION

 

This Agreement shall be governed by,
and construed and interpreted in accordance with, the laws of the State of Virginia of the United States of America without regard
to principles of conflict of laws. The State of Virginia shall be the exclusive jurisdiction for any disputes arising under this
Agreement and the Parties hereby consent to such jurisdiction.

 

16.           HEADINGS

 

The headings of paragraphs are inserted
for convenience and shall not affect any interpretation of this Agreement.

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the day and year first above written.

 

Corporation:

    	8

    	 

    

 

ADEONA PHARMACEUTICALS, INC.

 

	By:  		 
	 	 /s/
    Jeff Riley	 
	 	Title:   Authorized agent	 
	 	 	 
	 	 	 
	Executive:	 
	 	 	 
	 	 /s/ C. Evan Ballantyne	 
	 	C. Evan Ballantyne	 

 

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}]]